Masimo W1 Medical Watch Gets FDA Clearance for OTC and Prescription Use

Masimo 3Q EPS 20c >MASI

Masimo Surges After Winning A Potential $100 Million Battle Against Apple

Apple Stock Is Stumbling on iPhone Gloom. Now It Faces Another Headache.

Apple Faces Potential Watch Import Ban After Federal Trade Ruling

Masimo Shares Rise 11% After Agency Rules Apple Violated Patent

Masimo 2Q EPS 29c >MASI

Charles Schwab, Morgan Stanley, Bank of America, Masimo, and More Stock Market Movers

Masimo Crashes To Four-Year Low; Why It Could Take 'Months To Regain Footing'

Masimo's Weak Sales Forecast Sinks the Stock. What Has Wall Street Worried.

Masimo Plans to Lower 2023 Rev Guidance, 2Q Expected to Underperform

Masimo Sees 2Q Rev $453M-$457M >MASI

Masimo, Vera Therapeutics See Activist Action

Natural Gas Services, Masimo See Activist Investor Action

When Apple Comes Calling, ‘It’s the Kiss of Death’

Shockwave Medical Stock With Rising Relative Strength

FDA Grants Marketing Authorization to Masimo's Opioid-Overdose Tracking Device

Masimo, Veris Residential See Activist Investor Action

Masimo, ChannelAdvisor See Activist Action

New York Times, Masimo See Activist Action